Cite
Trajectory of health care resources among adults stopping or reducing treatment frequency of botulinum toxin for chronic migraine treatment in Alberta, Canada.
MLA
Richer, Lawrence, et al. “Trajectory of Health Care Resources among Adults Stopping or Reducing Treatment Frequency of Botulinum Toxin for Chronic Migraine Treatment in Alberta, Canada.” Headache: The Journal of Head & Face Pain, vol. 63, no. 9, Oct. 2023, pp. 1285–94. EBSCOhost, https://doi.org/10.1111/head.14613.
APA
Richer, L., Luu, H., Martins, K. J. B., Vu, K., Guigue, A., Wong, K. O., Nguyen, P. U., Rajapakse, T., Williamson, T., & Klarenbach, S. W. (2023). Trajectory of health care resources among adults stopping or reducing treatment frequency of botulinum toxin for chronic migraine treatment in Alberta, Canada. Headache: The Journal of Head & Face Pain, 63(9), 1285–1294. https://doi.org/10.1111/head.14613
Chicago
Richer, Lawrence, Huong Luu, Karen J. B. Martins, Khanh Vu, Alexis Guigue, Kai On Wong, Phuong Uyen Nguyen, Thilinie Rajapakse, Tyler Williamson, and Scott W. Klarenbach. 2023. “Trajectory of Health Care Resources among Adults Stopping or Reducing Treatment Frequency of Botulinum Toxin for Chronic Migraine Treatment in Alberta, Canada.” Headache: The Journal of Head & Face Pain 63 (9): 1285–94. doi:10.1111/head.14613.